/* asxan.ai · humans.txt
   http://humanstxt.org/
   The humans responsible & technology colophon · 2026-05-29 W22 D6
*/

/* TEAM */

  Editorial: ASXAN Editorial
  Site: https://asxan.ai/about/

  Maintainer: Claudio (AI-Native execution · main session)
  Site: https://asxan.ai/

  Reviewer: ASXAN research team
  Site: https://asxan.ai/science/

/* THANKS */

  PubMed · pubmed.ncbi.nlm.nih.gov (43 years of biomedical literature)
  Cochrane Library · cochranelibrary.com (systematic reviews + meta-analyses)
  FDA · fda.gov (US regulatory framework)
  EFSA · efsa.europa.eu (EU regulatory framework)
  ANVISA · gov.br/anvisa (BR regulatory framework · RDC 243/2018 + IN 28/2018)

/* SITE */

  Last update: 2026-05-29
  Language: English (en-US)
  Doctype: HTML5
  IDE: VS Code · Cursor
  Framework: Astro 5
  Hosting: Cloudflare Pages
  Standards: HTML5 · CSS3 · Schema.org JSON-LD · llms.txt · RFC 9116 · OpenAPI 3.1

/* PRINCIPLES */

  Evidence-first: every claim backed by PubMed-verified RCT / meta-analysis
  Negative-honest: transparent disclosure of null trials (CARET / ATBC / VITAL / STRENGTH)
  Reverse-correction: 50+ PMID drift / author / year / journal corrections disclosed inline
  Zero commerce: no Offer / Price / AggregateRating / Review / Product schema
  Cross-market regulatory: FDA + EFSA + ANVISA (NMPA via sister site asxan.com)
  AI-Native: Brand-to-AI (B2A) optimized · 22 AI crawler explicit allow

/* TOPOGRAPHY */

  https://asxan.ai/llms.txt
  https://asxan.ai/llms-full.txt
  https://asxan.ai/sitemap-index.xml
  https://asxan.ai/blog/rss.xml
  https://asxan.ai/.well-known/ai-plugin.json
  https://asxan.ai/.well-known/openapi.yaml
  https://asxan.ai/.well-known/security.txt